Scarica l'app Stockscreener
95.08
0.53%
-0.51
Dopo l'orario di chiusura:
95.60
0.52
+0.55%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$95.59
Aprire:
$95.91
Volume 24 ore:
15.66M
Relative Volume:
2.15
Capitalizzazione di mercato:
$121.96B
Reddito:
$34.20B
Utile/perdita netta:
$4.69B
Rapporto P/E:
26.19
EPS:
3.63
Flusso di cassa netto:
$5.30B
1 W Prestazione:
+1.12%
1M Prestazione:
+5.76%
6M Prestazione:
+3.49%
1 anno Prestazione:
+6.27%
Intervallo 1D:
$94.08
$95.91
Intervallo di 1 settimana:
$93.22
$95.91
Portata 52W:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Nome
Medtronic Plc
Settore
Industria
Telefono
01135314381700
Indirizzo
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Confronta MDT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-30 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-03-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-10-10 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Reiterato | Oppenheimer | Perform |
| 2024-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2024-08-14 | Downgrade | Stifel | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Sell |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Downgrade | UBS | Buy → Sell |
| 2023-01-09 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Downgrade | Citigroup | Buy → Neutral |
| 2022-11-23 | Downgrade | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-08-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Iniziato | Wolfe Research | Underperform |
| 2022-06-01 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-10 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-12-15 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Aggiornamento | Stifel | Hold → Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-05-14 | Downgrade | DZ Bank | Buy → Hold |
| 2020-03-30 | Downgrade | Needham | Strong Buy → Buy |
| 2020-03-25 | Aggiornamento | DZ Bank | Hold → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Sell |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-02 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-06-05 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Reiterato | Needham | Strong Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Downgrade | Citigroup | Buy → Neutral |
| 2018-12-19 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-27 | Reiterato | Argus | Buy |
Mostra tutto
Medtronic Plc Borsa (MDT) Ultime notizie
How Medtronic Plc. (MDT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Medtronic plc. (MDT) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Medtronic's Altaviva bags FDA approval for incontinence - BioWorld MedTech
Medtronic receives FDA approval for urinary incontinence device - Investing.com India
Medtronic gets FDA nod for implantable neuromod for urinary incontinence - MassDevice
Strategy To YieldBoost Medtronic To 9.9% Using Options - Nasdaq
Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025 - Yahoo Finance
FDA Greenlights Medtronic's (MDT) Bladder Control Device - GuruFocus
Medtronic's New Implant Could Transform Bladder Control Treatment - Benzinga
US FDA greenlights Medtronic's Altaviva - MarketScreener
Medtronic gets FDA nod for the Altaviva device (MDT:NYSE) - Seeking Alpha
Bone Grafts and Substitutes Market Size Worth USD 5.68 Billion by 2034 Fueled by Orthopedic Demand and Regenerative Innovations - GlobeNewswire Inc.
FDA approves Altaviva device for urge urinary incontinence - Urology Times
Medtronic (MDT) Gains FDA Approval for Altaviva Device - GuruFocus
FDA Approves Medtronic’s Altaviva Implantable Device for Urge Urinary Incontinence - geneonline.com
Medtronic gains FDA approval for Altaviva device to treat urge urinary incontinence - MarketScreener
Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence - Medtronic News
Revolutionary 15-Year Battery Life: Medtronic's New Altaviva Device Approved for 16M Bladder Control Patients - Stock Titan
Max Healthcare Partners With Medtronic To Launch State-Of-The-Art Surgical Skill Lab At Max Hospital, Saket. - TRIPURA STAR NEWS
Colibri Wants Full Fed. Circ. To Rethink Medtronic Patent Case - Law360
J&J launches IVL device in Europe; Medtronic looks at pacing for more patients - MedTech Dive
Medtronic (MDT) Up 1.5% Since Last Earnings Report: Can It Continue? - Yahoo
With 86% Ownership, Medtronic Plc (NYSE:MDT) Boasts of Strong Institutional Backing - 富途牛牛
Aug Intraday: Can IB Acquisition Corp expand into new marketsStock Surge & High Yield Equity Trading Tips - khodrobank.com
Lingohr Asset Management GmbH Sells 47,500 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Financiere des Professionnels Fonds d investissement inc. - MarketBeat
StrongBox Wealth LLC Sells 3,523 Shares of Medtronic PLC $MDT - MarketBeat
Procyon Advisors LLC Has $1.05 Million Position in Medtronic PLC $MDT - MarketBeat
Gateway Investment Advisers LLC Sells 12,576 Shares of Medtronic PLC $MDT - MarketBeat
Parallel Advisors LLC Has $1.81 Million Holdings in Medtronic PLC $MDT - MarketBeat
Kera Capital Partners Inc. Makes New Investment in Medtronic PLC $MDT - MarketBeat
Focus Partners Wealth Buys 12,533 Shares of Medtronic PLC $MDT - MarketBeat
Cullen Investment Group LTD. Has $7.49 Million Stake in Medtronic PLC $MDT - MarketBeat
Acadian Asset Management LLC Has $6.78 Million Stake in Medtronic PLC $MDT - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Has $2.28 Million Position in Medtronic PLC $MDT - MarketBeat
First Hawaiian Bank Increases Stock Position in Medtronic PLC $MDT - MarketBeat
Trend Review: Can Medtronic plc sustain earnings growthWeekly Trading Summary & Community Consensus Trade Alerts - خودرو بانک
Modern Wealth Management LLC Grows Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic prices $1.5 billion senior notes - MSN
Swedbank AB Raises Holdings in Medtronic PLC $MDT - MarketBeat
Hodges Capital Management Inc. Purchases 2,876 Shares of Medtronic PLC $MDT - MarketBeat
Jones Financial Companies Lllp Buys 168,092 Shares of Medtronic PLC $MDT - MarketBeat
Great Lakes Advisors LLC Has $314,000 Stock Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic announces pricing of €1.5 billion of senior notes - MSN
Voya Investment Management LLC Decreases Stock Holdings in Medtronic PLC $MDT - MarketBeat
12,317 Shares in Medtronic PLC $MDT Purchased by Integrity Alliance LLC. - MarketBeat
Potential CMS Policy Update Could Boost Medtronic (MDT) Adoption - GuruFocus
Medtronic: Buy This Dividend Aristocrat While It's Good Value (NYSE:MDT) - Seeking Alpha
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
New England Research & Management Inc. Decreases Position in Medtronic PLC $MDT - MarketBeat
Sentiment Watch: Does ABOS have a sustainable dividendJuly 2025 Rallies & Free Accurate Trade Setup Notifications - khodrobank.com
Medtronic Plc Azioni (MDT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
1.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):